These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 16531164

  • 1. Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome.
    Cagnacci A, Tirelli A, Renzi A, Paoletti AM, Volpe A.
    Contraception; 2006 Apr; 73(4):348-51. PubMed ID: 16531164
    [Abstract] [Full Text] [Related]

  • 2. Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel.
    Cagnacci A, Paoletti AM, Renzi A, Orrù M, Pilloni M, Melis GB, Volpe A.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3621-5. PubMed ID: 12915645
    [Abstract] [Full Text] [Related]

  • 3. Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial.
    Cagnacci A, Ferrari S, Tirelli A, Zanin R, Volpe A.
    Contraception; 2009 Feb; 79(2):111-6. PubMed ID: 19135567
    [Abstract] [Full Text] [Related]

  • 4. The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
    Gul OB, Somunkiran A, Yucel O, Demirci F, Ozdemir I.
    Arch Gynecol Obstet; 2008 Jan; 277(1):25-30. PubMed ID: 17618446
    [Abstract] [Full Text] [Related]

  • 5. Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study.
    Cagnacci A, Ferrari S, Tirelli A, Zanin R, Volpe A.
    Contraception; 2009 Jul; 80(1):34-9. PubMed ID: 19501213
    [Abstract] [Full Text] [Related]

  • 6. Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
    Lemay A, Dodin S, Turcot L, Déchêne F, Forest JC.
    Hum Reprod; 2006 Jan; 21(1):121-8. PubMed ID: 16199428
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate.
    Markantes G, Saltamavros AD, Vervita V, Armeni AK, Karela A, Adonakis G, Decavalas G, Georgopoulos NA.
    Gynecol Endocrinol; 2011 Dec; 27(12):971-7. PubMed ID: 21501001
    [Abstract] [Full Text] [Related]

  • 9. Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study.
    Makedos A, Goulis DG, Papanikolaou A, Panidis D.
    Angiology; 2010 Aug; 61(6):595-601. PubMed ID: 20395229
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 12. Effects of two different low-dose oral contraceptives on plasma homocysteine levels.
    Odabaşi AR, Küçük M, Yüksel H, Güner Z, Sezer SD.
    Gynecol Endocrinol; 2011 Mar; 27(3):176-9. PubMed ID: 20504105
    [Abstract] [Full Text] [Related]

  • 13. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
    Palombo-Kinne E, Schellschmidt I, Schumacher U, Gräser T.
    Contraception; 2009 Apr; 79(4):282-9. PubMed ID: 19272497
    [Abstract] [Full Text] [Related]

  • 15. Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial.
    Kilicdag EB, Bagis T, Tarim E, Aslan E, Erkanli S, Simsek E, Haydardedeoglu B, Kuscu E.
    Hum Reprod; 2005 Jun; 20(6):1521-8. PubMed ID: 15790610
    [Abstract] [Full Text] [Related]

  • 16. Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome.
    Carlsen SM, Kjøtrød S, Vanky E, Romundstad P.
    Acta Obstet Gynecol Scand; 2007 Jun; 86(2):145-50. PubMed ID: 17364275
    [Abstract] [Full Text] [Related]

  • 17. The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD.
    Seaman HE, de Vries CS, Farmer RD.
    Pharmacoepidemiol Drug Saf; 2003 Jun; 12(7):541-50. PubMed ID: 14558177
    [Abstract] [Full Text] [Related]

  • 18. Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients.
    Kebapcilar L, Kebapcilar AG, Bilgir O, Taner CE, Bozkaya G, Yildiz Y, Sari I.
    Gynecol Endocrinol; 2011 Feb; 27(2):91-5. PubMed ID: 20528207
    [Abstract] [Full Text] [Related]

  • 19. Plasma homocysteine concentrations and the single nucleotide polymorphisms in the methionine synthase gene (MTR 2756A>G): Associations with the polycystic ovary syndrome An observational study.
    Palep-Singh M, Picton HM, Yates ZR, Barth JH, Balen AH.
    Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):180-6. PubMed ID: 18281142
    [Abstract] [Full Text] [Related]

  • 20. Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome.
    Adeniji AA, Essah PA, Nestler JE, Cheang KI.
    J Womens Health (Larchmt); 2016 Jun; 25(6):638-45. PubMed ID: 26871978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.